p.139 抽出テキスト

Consensus (TASC). J Vasc Surg 2000; 31 Suppl: S1-S296. PMID: 10666287 167. Marston WA, Davies SW, Armstrong B, et al. Natural history of limbs with arterial insufficiency and chronic ulceration treated without revascularization. J Vasc Surg 2006; 44: 108-114. PMID: 16828434 168. Abu Dabrh AM, Steffen MW, Undavalli C, et al. The natural history of untreated severe or critical limb ischemia. J Vasc Surg 2015; 62: 1642-1651. PMID: 26391460 169. Iida O, Takahara M, Soga Y, et al. PRIORITY Investigators. Prognostic Impact of Revascularization in Poor-Risk Patients With Critical Limb Ischemia: The PRIORITY Registry (Poor-Risk Patients With and Without Revascularization Therapy for Critical Limb Ischemia). JACC Cardiovasc Interv 2017; 10: 1147-1157. PMID: 28595883 170. Koch M, Trapp R, Kulas W, et al. Critical limb ischaemia as a main cause of death in patients with end-stage renal disease: a single-centre study. Nephrol Dial Transplant 2004; 19: 2547-2552. PMID: 15266035 171. Orimoto Y, Ohta T, Ishibashi H, et al. The prognosis of patients on hemodialysis with foot lesions. J Vasc Surg 2013; 58: 1291-1299. PMID: 23810259 172. Bhatt DL, Steg PG, Ohman EM, et al. REACH Registry Investigators. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA 2006; 295: 180-189. PMID: 16403930 173. Steg PG, Bhatt DL, Wilson PW, et al. REACH Registry Investigators. One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA 2007; 297: 1197-1206. PMID: 17374814 174. Cacoub PP, Abola MT, Baumgartner I, et al. REACH Registry Investigators. Cardiovascular risk factor control and outcomes in peripheral artery disease patients in the Reduction of Atherothrombosis for Continued Health (REACH) Registry. Atherosclerosis 2009; 204: e86-e92. PMID: 19054514 175. Criqui MH, Aboyans V. Epidemiology of peripheral artery disease. Circ Res 2015; 116: 1509-1526. PMID: 25908725 176. Bhatt DL, Eagle KA, Ohman EM, et al. REACH Registry Investigators. Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis. JAMA 2010; 304: 1350-1357. PMID: 20805624 177. Singh S, Bailey KR, Noheria A, et al. Frailty across the spectrum of ankle-brachial index. Angiology 2012; 63: 229-236. PMID: 21733950 178. McDermott MM, Liu K, Tian L, et al. Calf muscle characteristics, strength measures, and mortality in peripheral arterial disease: A longitudinal study. J Am Coll Cardiol 2012; 59: 1159-1167. PMID: 22440216 179. Matsuo Y, Kumakura H, Kanai H, et al. The Geriatric Nutritional Risk Index Predicts Long-Term Survival and Cardiovascular or Limb Events in Peripheral Arterial Disease. J Atheroscler Thromb 2020; 27: 134-143. PMID: 31217396 180. Sartipy F, Sigvant B, Lundin F, et al. Ten Year Mortality in Different Peripheral Arterial Disease Stages: A Population Based Observational Study on Outcome. Eur J Vasc Endovasc Surg 2018; 55: 529- 536. PMID: 29478910 181. Newman AB, Shemanski L, Manolio TA, et al. The Cardiovascular Health Study Group. Ankle-arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study. Arterioscler Thromb Vasc Biol 1999; 19: 538-545. PMID: 10073955 182. Diehm C, Allenberg JR, Pittrow D, et al. German Epidemiological Trial on Ankle Brachial Index Study Group. Mortality and vascular morbidity in older adults with asymptomatic versus symptomatic peripheral artery disease. Circulation 2009; 120: 2053-2061. PMID: 19901192 183. Harada M, Matsuzawa R, Aoyama N, et al. Asymptomatic peripheral artery disease and mortality in patients on hemodialysis. Ren Replace Ther 2018; 4: 17. 184. Kumakura H, Kanai H, Hojo Y, et al. Long-term survival and fate of the leg in de novo intermittent claudication. Eur Heart J Qual Care Clin Outcomes 2017; 3: 208-215. PMID: 28838085 185. Eraso LH, Fukaya E, Mohler ER 3rd, et al. Peripheral arterial disease, prevalence and cumulative risk factor profile analysis. Eur J Prev Cardiol 2014; 21: 704-711. PMID: 22739687 186. Pande RL, Perlstein TS, Beckman JA, et al. Secondary prevention and mortality in peripheral artery disease: National Health and Nutrition Examination Study, 1999 to 2004. Circulation 2011; 124: 17- 23. PMID: 21690489 187. Welten GM, Schouten O, Hoeks SE, et al. Long-term prognosis of

patients with peripheral arterial disease: A comparison in patients with coronary artery disease. J Am Coll Cardiol 2008; 51: 1588- 1596. PMID: 18420103 188. Gallino A, Aboyans V, Diehm C, et al. Non-coronary atherosclero-

sis. Eur Heart J 2014; 35: 1112-1119. PMID: 24595865 189. Lane DA, Lip GY. Treatment of hypertension in peripheral arterial disease. Cochrane Database Syst Rev 2013: CD003075. PMID: 24307487 190. Thomas Manapurathe D, Krishna SM, Dewdney B, et al. Effect of blood pressure lowering medications on leg ischemia in peripheral artery disease patients: A meta-analysis of randomised controlled trials. PLoS One 2017; 12: e0178713. PMID: 28575088 191. Ahimastos AA, Walker PJ, Askew C, et al. Effect of ramipril on walking times and quality of life among patients with peripheral artery disease and intermittent claudication: A randomized controlled trial. JAMA 2013; 309: 453-460. PMID: 23385271 192. Song P, Rudan D, Wang M, et al. National and subnational estimation of the prevalence of peripheral artery disease (PAD) in China: a systematic review and meta-analysis. J Glob Health 2019; 9: 010601. PMID: 30873278 193. Mehler PS, Coll JR, Estacio R, et al. Intensive blood pressure control reduces the risk of cardiovascular events in patients with peripheral arterial disease and type 2 diabetes. Circulation 2003; 107: 753- 756. PMID: 12578880 194. Itoga NK, Tawfik DS, Lee CK, et al. Association of blood pressure measurements with peripheral artery disease events: Reanalysis of the ALLHAT data. Circulation 2018; 138: 1805-1814. PMID: 29930023 195. Radack K, Deck C. ß-adrenergic blocker therapy does not worsen intermittent claudication in subjects with peripheral arterial disease: A meta-analysis of randomized controlled trials. Arch Intern Med 1991; 151: 1769-1776. PMID: 1679624 196. Shetty S, Malik AH, Feringa H, et al. Meta-Analysis Evaluating Calcium Channel Blockers and the Risk of Peripheral Arterial Disease in Patients With Hypertension. Am J Cardiol 2020; 125: 907- 915. PMID: 31959429 197. Hicks CW, Yang C, Ndumele CE, et al. Associations of Obesity With Incident Hospitalization Related to Peripheral Artery Disease and Critical Limb Ischemia in the ARIC Study. J Am Heart Assoc 2018; 7: e008644. PMID: 30369315 198. 日本肥満学会.肥満症診療ガイドライン2016.ライフサイエンス出版 2016. 199. Murata N, Soga Y, Iida O, et al. Complex relationship of body mass index with mortality in patients with critical limb ischemia undergoing endovascular treatment. Eur J Vasc Endovasc Surg 2015; 49: 297-305. PMID: 25524520 200. Senda K, Miura T, Minamisawa M, et al. Predictive Value of Underweight Status for Patients With Peripheral Artery Disease With Claudication. Angiology 2018; 69: 513-522. PMID: 29088925 201. Takahara M, Soga Y, Fujihara M, et al. Association of Age with Mortality Rate after Femoropopliteal Endovascular Therapy for Intermittent Claudication. J Atheroscler Thromb 2021 Feb 27. doi: 10.5551/jat.62356 PMID: 33642442 202. Takahara M, Iida O, Soga Y, et al. SPINACH study investigators. Current and Past Obesity in Japanese Patients with Critical Limb Ischemia Undergoing Revascularization. J Atheroscler Thromb 2021; 28: 44-51. PMID: 32188794 203. Bradbury AW, Adam DJ, Bell J, et al. BASIL Trial Participants. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: A survival prediction model to facilitate clinical decision making. J Vasc Surg 2010; 51 Suppl: 52S-68S. PMID: 20435262 204. Shiraki T, Iida O, Takahara M, et al. Predictive scoring model of mortality after surgical or endovascular revascularization in patients with critical limb ischemia. J Vasc Surg 2014; 60: 383-389. PMID: 24726827 205. Soga Y, Iida O, Takahara M, et al. Two-year life expectancy in patients with critical limb ischemia. JACC Cardiovasc Interv 2014; 7: 1444-1449. PMID: 25523536 206. Azuma N, Takahara M, Kodama A, et al. Predictive Model for Mortality Risk Including the Wound, Ischemia, Foot Infection Classification in Patients Undergoing Revascularization for Critical Limb Ischemia. Circ Cardiovasc Interv 2019; 12: e008015. PMID: 31771341 207. Shiraki T, Takahara M, Iida O, et al. SPINACH study investigators. Baseline and Updated Information on Nutritional Status in Patients With Chronic Limb Threatening Ischaemia Undergoing Revascularisation. Eur J Vasc Endovasc Surg 2021; 61: 467-472. PMID: 33358104 208. Hata Y, Iida O, Asai M, et al. Risk Stratification for 2-Year Mortality

in Patients with Chronic Limb-Threatening Ischemia Undergoing Endovascular Therapy. J Atheroscler Thromb 2021; 28: 477-482. PMID: 32713933